Intervention Protocol

Mepolizumab versus placebo for asthma

  1. Colin Powell1,*,
  2. Stephen J Milan2,
  3. Kerry Dwan3,
  4. Nicola Walters4

Editorial Group: Cochrane Airways Group

Published Online: 15 NOV 2013

DOI: 10.1002/14651858.CD010834


How to Cite

Powell C, Milan SJ, Dwan K, Walters N. Mepolizumab versus placebo for asthma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010834. DOI: 10.1002/14651858.CD010834.

Author Information

  1. 1

    Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Department of Child Health, Cardiff, UK

  2. 2

    St George's, University of London, Population Health Sciences and Education, London, UK

  3. 3

    University of Liverpool, Department of Biostatistics, Liverpool, England, UK

  4. 4

    St George's NHS Healthcare Trust, Chest Unit, London, UK

*Colin Powell, Department of Child Health, Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, UK. PowellC7@cardiff.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 15 NOV 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of mepolizumab with placebo on exacerbations and HRQoL in adults and children with chronic asthma.